Nationwide Variable Insurance Trust has made a notable update to its Summary Prospectus by filing a supplement that is effective immediately. The filing indicates that all references to Keith P. Robinette, CFA, have been deleted from the document. This change suggests a significant shift in the company's leadership and may impact its investment strategies moving forward.
Nationwide Variable Insurance Trust, based in Columbus, Ohio, is an investment entity that operates under the SEC file number 002-73024. The company is incorporated in Delaware and has a fiscal year ending on December 31. It has undergone several name changes in the past, including its former names, Gartmore Variable Insurance Trust and Nationwide Separate Account Trust.
The recent filing, accession number 0002071844-26-001596, reveals that the supplement is dated October 29, 2026, and is intended to update the existing Summary Prospectus dated April 30, 2026. The filing states, "Effective immediately, all references to, and information regarding, Keith P. Robinette, CFA in the Summary Prospectus are deleted in their entirety." This indicates a clear move away from Robinette's involvement with the trust.
This change may affect investors and stakeholders associated with the NVIT Investor Destinations Moderate Fund, as they may need to adjust their expectations and strategies based on the new leadership direction. The filing does not specify what will happen next or who will take over the responsibilities previously held by Robinette.
As the investment industry continues to evolve, other firms may look to adapt their strategies in response to leadership changes like this. The filing does not indicate any upcoming votes or additional filings related to this change, leaving stakeholders to await further developments.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






